These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28471826)

  • 41. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.
    Kurti Z; Vegh Z; Golovics PA; Fadgyas-Freyler P; Gecse KB; Gonczi L; Gimesi-Orszagh J; Lovasz BD; Lakatos PL
    Dig Liver Dis; 2016 Nov; 48(11):1302-1307. PubMed ID: 27481587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comorbid immune-mediated diseases in inflammatory bowel disease: a nation-wide population-based study.
    Park SW; Kim TJ; Lee JY; Kim ER; Hong SN; Chang DK; Yang M; Kim S; Shin MH; Kim YH
    Aliment Pharmacol Ther; 2019 Jan; 49(2):165-172. PubMed ID: 30506945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High prevalence of inflammatory bowel disease in United States residents of Indian ancestry.
    Malhotra R; Turner K; Sonnenberg A; Genta RM
    Clin Gastroenterol Hepatol; 2015 Apr; 13(4):683-9. PubMed ID: 25083563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals.
    Voegtlin M; Vavricka SR; Schoepfer AM; Straumann A; Voegtlin J; Rogler G; Ballabeni P; Pittet V; Buser A; Fried M; Beglinger C;
    J Crohns Colitis; 2010 Dec; 4(6):642-8. PubMed ID: 21122574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009.
    Pant C; Anderson MP; Deshpande A; Grunow JE; O'Connor JA; Philpott JR; Sferra TJ
    J Investig Med; 2013 Aug; 61(6):1036-8. PubMed ID: 23797749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease.
    Blaney H; Vu P; Mathew A; Snelling R; England J; Duong C; Hammonds K; Johnson C
    Dig Dis Sci; 2021 Aug; 66(8):2555-2563. PubMed ID: 32892260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients.
    Sridhar AR; Parasa S; Navaneethan U; Crowell MD; Olden K
    J Crohns Colitis; 2011 Aug; 5(4):287-94. PubMed ID: 21683298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiple chronic conditions and associated health care expenses in US adults with cancer: a 2010-2015 Medical Expenditure Panel Survey study.
    Davis-Ajami ML; Lu ZK; Wu J
    BMC Health Serv Res; 2019 Dec; 19(1):981. PubMed ID: 31856797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases.
    Roka K; Roma E; Stefanaki K; Panayotou I; Kopsidas G; Chouliaras G
    J Crohns Colitis; 2013 Nov; 7(10):797-802. PubMed ID: 23207168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease.
    Dimitrova AK; Ungaro RC; Lebwohl B; Lewis SK; Tennyson CA; Green MW; Babyatsky MW; Green PH
    Headache; 2013 Feb; 53(2):344-55. PubMed ID: 23126519
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
    Zand A; van Deen WK; Inserra EK; Hall L; Kane E; Centeno A; Choi JM; Ha CY; Esrailian E; DʼHaens GR; Hommes DW
    Inflamm Bowel Dis; 2015 Jul; 21(7):1623-30. PubMed ID: 26070004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
    Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
    Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estimating the prevalence of comorbid conditions and their effect on health care costs in patients with diabetes mellitus in Switzerland.
    Huber CA; Diem P; Schwenkglenks M; Rapold R; Reich O
    Diabetes Metab Syndr Obes; 2014; 7():455-65. PubMed ID: 25336981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease.
    Bosch DE; Yeh MM
    Hum Pathol; 2017 Nov; 69():55-62. PubMed ID: 28970141
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic Comorbidities Contribute to the Burden and Costs of Persistent Asthma.
    Kauppi P; Linna M; Jantunen J; Martikainen JE; Haahtela T; Pelkonen A; Mäkelä M
    Mediators Inflamm; 2015; 2015():819194. PubMed ID: 26783384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003.
    Vijverman A; Piront P; Belaiche J; Louis E
    Acta Gastroenterol Belg; 2006; 69(1):1-4. PubMed ID: 16673554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health care resource utilization in inflammatory bowel disease.
    Longobardi T; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.